Self-assembled glycol chitosan nanoparticles for disease-specific theranostics

Ji Young Yhee, Sohee Son, Sun Hwa Kim, Kinam Park, Kuiwon Choi, Ick Chan Kwon

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Hydrophobically modified glycol chitosan (hGC) conjugates spontaneously form self-assembled nanoparticles (NPs) in aqueous conditions, and glycol chitosan NPs (CNPs) have been extensively studied for the past few decades. For disease-specific theranostics, CNPs could be simply modified with imaging agents, and the hydrophobic domains of hGC are available for encapsulation of various drugs. Based on the excellent physiochemical and biological properties, CNPs have been investigated for multimodal imaging and target specific drug delivery. In particular, a recent application of CNPs has shown great potential as an efficient theranostic system because the CNPs could be utilized for a disease-specific theranostic delivery system of different imaging agents and therapeutics, simultaneously. Furthermore, various therapeutic agents including chemo-drugs, nucleotides, peptides, and photodynamic chemicals could be simply encapsulated into the CNPs through hydrophobic or charge-charge interactions. Under in vivo conditions, the encapsulated imaging agents and therapeutic drugs have been successfully delivered to targeted diseases. In this article, the overall research progress on CNPs is reviewed from early works. The current challenges of CNPs to overcome in theranostics are also discussed, and continuous studies would provide more opportunities for early diagnosis of diseases and personalized medicine.

Original languageEnglish
Pages (from-to)202-213
Number of pages12
JournalJournal of Controlled Release
Volume193
DOIs
Publication statusPublished - 2014 Nov 10

Fingerprint

Chitosan
Nanoparticles
Pharmaceutical Preparations
Multimodal Imaging
Precision Medicine
Theranostic Nanomedicine
glycol-chitosan
Early Diagnosis
Therapeutics
Nucleotides
Peptides
Research

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Self-assembled glycol chitosan nanoparticles for disease-specific theranostics. / Yhee, Ji Young; Son, Sohee; Kim, Sun Hwa; Park, Kinam; Choi, Kuiwon; Kwon, Ick Chan.

In: Journal of Controlled Release, Vol. 193, 10.11.2014, p. 202-213.

Research output: Contribution to journalArticle

Yhee, Ji Young ; Son, Sohee ; Kim, Sun Hwa ; Park, Kinam ; Choi, Kuiwon ; Kwon, Ick Chan. / Self-assembled glycol chitosan nanoparticles for disease-specific theranostics. In: Journal of Controlled Release. 2014 ; Vol. 193. pp. 202-213.
@article{b752e7a68ecf43159c6a95e57b60f057,
title = "Self-assembled glycol chitosan nanoparticles for disease-specific theranostics",
abstract = "Hydrophobically modified glycol chitosan (hGC) conjugates spontaneously form self-assembled nanoparticles (NPs) in aqueous conditions, and glycol chitosan NPs (CNPs) have been extensively studied for the past few decades. For disease-specific theranostics, CNPs could be simply modified with imaging agents, and the hydrophobic domains of hGC are available for encapsulation of various drugs. Based on the excellent physiochemical and biological properties, CNPs have been investigated for multimodal imaging and target specific drug delivery. In particular, a recent application of CNPs has shown great potential as an efficient theranostic system because the CNPs could be utilized for a disease-specific theranostic delivery system of different imaging agents and therapeutics, simultaneously. Furthermore, various therapeutic agents including chemo-drugs, nucleotides, peptides, and photodynamic chemicals could be simply encapsulated into the CNPs through hydrophobic or charge-charge interactions. Under in vivo conditions, the encapsulated imaging agents and therapeutic drugs have been successfully delivered to targeted diseases. In this article, the overall research progress on CNPs is reviewed from early works. The current challenges of CNPs to overcome in theranostics are also discussed, and continuous studies would provide more opportunities for early diagnosis of diseases and personalized medicine.",
keywords = "Glycol chitosan, Nanoparticles, Targeted delivery, Theranostics",
author = "Yhee, {Ji Young} and Sohee Son and Kim, {Sun Hwa} and Kinam Park and Kuiwon Choi and Kwon, {Ick Chan}",
year = "2014",
month = "11",
day = "10",
doi = "10.1016/j.jconrel.2014.05.009",
language = "English",
volume = "193",
pages = "202--213",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Self-assembled glycol chitosan nanoparticles for disease-specific theranostics

AU - Yhee, Ji Young

AU - Son, Sohee

AU - Kim, Sun Hwa

AU - Park, Kinam

AU - Choi, Kuiwon

AU - Kwon, Ick Chan

PY - 2014/11/10

Y1 - 2014/11/10

N2 - Hydrophobically modified glycol chitosan (hGC) conjugates spontaneously form self-assembled nanoparticles (NPs) in aqueous conditions, and glycol chitosan NPs (CNPs) have been extensively studied for the past few decades. For disease-specific theranostics, CNPs could be simply modified with imaging agents, and the hydrophobic domains of hGC are available for encapsulation of various drugs. Based on the excellent physiochemical and biological properties, CNPs have been investigated for multimodal imaging and target specific drug delivery. In particular, a recent application of CNPs has shown great potential as an efficient theranostic system because the CNPs could be utilized for a disease-specific theranostic delivery system of different imaging agents and therapeutics, simultaneously. Furthermore, various therapeutic agents including chemo-drugs, nucleotides, peptides, and photodynamic chemicals could be simply encapsulated into the CNPs through hydrophobic or charge-charge interactions. Under in vivo conditions, the encapsulated imaging agents and therapeutic drugs have been successfully delivered to targeted diseases. In this article, the overall research progress on CNPs is reviewed from early works. The current challenges of CNPs to overcome in theranostics are also discussed, and continuous studies would provide more opportunities for early diagnosis of diseases and personalized medicine.

AB - Hydrophobically modified glycol chitosan (hGC) conjugates spontaneously form self-assembled nanoparticles (NPs) in aqueous conditions, and glycol chitosan NPs (CNPs) have been extensively studied for the past few decades. For disease-specific theranostics, CNPs could be simply modified with imaging agents, and the hydrophobic domains of hGC are available for encapsulation of various drugs. Based on the excellent physiochemical and biological properties, CNPs have been investigated for multimodal imaging and target specific drug delivery. In particular, a recent application of CNPs has shown great potential as an efficient theranostic system because the CNPs could be utilized for a disease-specific theranostic delivery system of different imaging agents and therapeutics, simultaneously. Furthermore, various therapeutic agents including chemo-drugs, nucleotides, peptides, and photodynamic chemicals could be simply encapsulated into the CNPs through hydrophobic or charge-charge interactions. Under in vivo conditions, the encapsulated imaging agents and therapeutic drugs have been successfully delivered to targeted diseases. In this article, the overall research progress on CNPs is reviewed from early works. The current challenges of CNPs to overcome in theranostics are also discussed, and continuous studies would provide more opportunities for early diagnosis of diseases and personalized medicine.

KW - Glycol chitosan

KW - Nanoparticles

KW - Targeted delivery

KW - Theranostics

UR - http://www.scopus.com/inward/record.url?scp=84908277949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908277949&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2014.05.009

DO - 10.1016/j.jconrel.2014.05.009

M3 - Article

C2 - 24845129

AN - SCOPUS:84908277949

VL - 193

SP - 202

EP - 213

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -